Eagle Pharmaceuticals Inc
SWB:1E6
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Eagle Pharmaceuticals Inc
SWB:1E6
|
US |
|
Black Box Entertainment Ltd
OTC:BBOE
|
US |
|
A
|
Auric Resources Corp
XTSX:RES
|
CA |
|
C
|
Cardno Ltd
OTC:COLDF
|
AU |
|
Premier American Uranium Inc
F:B05
|
CA |
|
SMA Alliance Inc
OTC:SMAA
|
US |
|
Biopower Operations Corp
OTC:BOPO
|
US |
|
Aeon Ventures Inc
OTC:IDEA
|
US |
|
Y
|
Yuanta Futures Co Ltd
TPEX:6023
|
TW |
|
D
|
Daiwa Securities Group Inc
SWB:DSE
|
JP |
|
Broad Street Realty Inc
OTC:BRST
|
US |
|
S
|
Suprema HQ Inc
KOSDAQ:094840
|
KR |
|
C
|
Cosmosteel Holdings Ltd
XMUN:CMR
|
SG |
Shareholder Yield
Current shareholder yield for 
Eagle Pharmaceuticals Inc is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Price
Eagle Pharmaceuticals Inc
| Average Annual Return | -16.95% |
| Standard Deviation of Annual Returns | 33.98% |
| Max Drawdown | -94% |
| Market Capitalization | 6.9m EUR |
| Shares Outstanding | 102 733 721 |
| Percentage of Shares Shorted |
N/A
|
